(Q35125115)

6 August 2017

1 reference

title

Regulation of cell proliferation and cell death by peroxisome proliferators (English)

1 reference

6 August 2017

1 reference

Russell C. Cattley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12740824

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12740824

1 January 2024

publication date

1 June 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjemt.10327

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/jemt.10327

1 January 2024

1 reference

Microscopy Research and Technique

1 January 2024

published in

1 reference

6 August 2017

volume

61

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

179-184

1 reference

Species differences in peroxisome proliferation; mechanisms and relevance.

6 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJEMT.10327

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJEMT.10327

Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling

21 January 2018

1

1 reference

Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver.

1 January 2024

2

1 reference

Peroxisome proliferators activate Kupffer cells in vivo

1 January 2024

3

1 reference

Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643

1 January 2024

4

1 reference

Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats.

1 January 2024

5

1 reference

Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

1 January 2024

6

1 reference

Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens

1 January 2024

8

1 reference

Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration

1 January 2024

9

1 reference

Cytokine regulation of liver injury and repair

1 January 2024

10

1 reference

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

1 January 2024

11

1 reference

1 January 2024

Liver regeneration

12

1 reference

In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note

1 January 2024

14

1 reference

Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.

1 January 2024

15

1 reference

Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia

1 January 2024

16

1 reference

Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility

1 January 2024

17

1 reference

Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.

1 January 2024

18

1 reference

Early effects of CI-924 on hepatic peroxisome proliferation, microsomal enzyme induction, PCNA, and apoptosis in B6C3F1 mice and Wistar rats

1 January 2024

19

1 reference

Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin

1 January 2024

20

1 reference

Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB).

1 January 2024

21

1 reference

Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats

1 January 2024

23

1 reference

Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig.

1 January 2024

25

1 reference

Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset

1 January 2024

26

1 reference

Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation

1 January 2024

27

1 reference

In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway.

1 January 2024

28

1 reference

Apoptosis, oncosis, and necrosis. An overview of cell death

1 January 2024

30

1 reference

Species differences in ciprofibrate induction of hepatic cytochrome p450 4A1 and peroxisome proliferation

1 January 2024

31

1 reference

Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid

1 January 2024

33

1 reference

Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.

1 January 2024

34

1 reference

Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.

1 January 2024

35

1 reference

Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas

1 January 2024

36

1 reference

Hepatocyte proliferation induced by a single dose of a peroxisome proliferator

1 January 2024

37

1 reference

Peroxisome proliferator activated receptor-alpha expression in human liver.

1 January 2024

38

1 reference

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

1 January 2024

39

1 reference

Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.

1 January 2024

40

1 reference

Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster

1 January 2024

41

1 reference

Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans

1 January 2024

42

1 reference

Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences

1 January 2024

43

1 reference

Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.

1 January 2024

44

1 reference

Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators

1 January 2024

45

1 reference

WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes

1 January 2024

46

1 reference

Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators

1 January 2024

47

1 reference

Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate

1 January 2024

48

1 reference

Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration

1 January 2024

49

1 reference

Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice

1 January 2024

50

1 reference

Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin

1 January 2024

51

1 reference

1 January 2024

Identifiers

DOI

10.1002/JEMT.10327

1 reference

6 August 2017

1 reference